Pediatr Endocrinol Diabetes Metab. 2020;26(2):89-96. doi: 10.5114/pedm.2020.95623.
Chronic hyperglycaemia, the effect of which is enhanced with diabetes duration and poor compensation, has a great impact on the complex aetiopathogenesis of microvascular diabetic complications. However, other factors are particularly likely in young patients with early onset of chronic complications. One of the possible risk factors is procoagulant condition, which can lead to small vessel microthromboses, endothelial damage, and ultimately specific organ manifestations. While these changes are well described in a group of adult patients with type 2 diabetes, similar information is less in the population of children and adults with type 1 diabetes (T1D). Changes in haemostasis may be associated with hyperglycaemia and subclinical inflammation or specific gene polymorphisms. Alternatively, they can occur due to coincidence with inherited thrombophilic disorders or sticky platelet syndrome. Finally, T1D is an autoimmune disease that can be associated with other autoimmune conditions, e.g. lupus anticoagulant. From the clinical point of view, mainly cases with early onset of chronic diabetic complications that cannot be explained by long duration or insufficient compensation of diabetes might be suspicious from the procoagulant changes and their screening might be discussed.
慢性高血糖症的影响随着糖尿病病程的延长和补偿不良而增强,对微血管糖尿病并发症的复杂发病机制有重大影响。然而,在慢性并发症早期发病的年轻患者中,其他因素尤其可能起作用。一个可能的危险因素是促凝状态,它可导致小血管微血栓形成、内皮损伤,并最终导致特定器官表现。虽然这些变化在一组 2 型糖尿病成年患者中得到了很好的描述,但在儿童和 1 型糖尿病(T1D)成年患者中,类似的信息较少。止血变化可能与高血糖和亚临床炎症或特定基因多态性有关。或者,它们可能由于与遗传性血栓形成倾向疾病或粘性血小板综合征同时发生而发生。最后,T1D 是一种自身免疫性疾病,可与其他自身免疫性疾病相关,例如狼疮抗凝剂。从临床角度来看,主要是那些慢性糖尿病并发症早期发病且不能用糖尿病病程长或补偿不足来解释的病例,可能与促凝变化有关,可能需要讨论其筛查。